Giancarlo Abis

Development of a specific and potent IGF2BP1 inhibitor: A promising therapeutic agent for IGF2BP1-expressing cancers.

V. Spiegelman, F. Oberman, Vikash Singh, 2023, European journal of medicinal chemistry.